|
You are here |
peckford42.wordpress.com | ||
| | | | |
www.frontiersin.org
|
|
| | | | | Background: The ongoing coronavirus disease-19 (COVID-19) pandemic (caused by an infection with severe acute respiratory syndrome (SARS)-coronavirus (CoV-2) ... | |
| | | | |
www.nature.com
|
|
| | | | | Timely evaluation of the protective effects of Coronavirus Disease 2019 (COVID-19) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern is urgently needed to inform pandemic control planning. Based on 78 vaccine efficacy or effectiveness (VE) data from 49 studies and 1,984,241 SARS-CoV-2 sequences collected from 31 regions, we analyzed the relationship between genetic distance (GD) of circulating viruses against the vaccine strain and VE against symptomatic in... | |
| | | | |
www.wired.com
|
|
| | | | | The first vaccine candidate entered human trials five days after the pandemic was declared. Behind the scenes at Moderna and an unprecedented global sprint. | |
| | | | |
brighterworld.mcmaster.ca
|
|
| | | Update, March 3, 2022: Human clinical trials for these vaccines have begun and are ongoing. This story was originally published on Dec. 7, 2021. Human . . . | ||